Next Article in Journal
Development of a UPLC-TQ/MS Approach for the Determination of Eleven Bioactive Components in Haizao Yuhu Decoction Plus-Minus Haizao and Gancao Drug Combination after Oral Administration in a Rat Model of Hypothyroidism
Previous Article in Journal
New Stable Cu(I) Catalyst Supported on Weakly Acidic Polyacrylate Resin for Green C-N Coupling: Synthesis of N-(Pyridin-4-yl)benzene Amines and N,N-Bis(pyridine-4-yl)benzene Amines
Article Menu
Issue 1 (January) cover image

Export Article

Open AccessReview
Molecules 2017, 22(1), 4;

Development and Structural Modification of BACE1 Inhibitors

Industrialization and Formulae Innovative Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, Jiangsu, China
Author to whom correspondence should be addressed.
Academic Editor: Diego Muñoz-Torrero
Received: 22 October 2016 / Revised: 13 December 2016 / Accepted: 20 December 2016 / Published: 22 December 2016
Full-Text   |   PDF [2298 KB, uploaded 22 December 2016]   |  


Alzheimer’s disease (AD) is a progressive neurodegenerative disorder which usually occurs in the elderly. The accumulation of β-amyloid and the formation of neurofibrillary tangles are considered as the main pathogenies of AD. Research suggests that β-secretase 1 (BACE1) plays an important role in the formation of β-amyloid. Discovery of new BACE1 inhibitors has become a significant method to slow down the progression of AD or even cure this kind of disease. This review summarizes the different types and the structural modification of these new BACE1 inhibitors. View Full-Text
Keywords: Alzheimer’s disease; β-amyloid; BACE1; BACE1 inhibitors; structural modification Alzheimer’s disease; β-amyloid; BACE1; BACE1 inhibitors; structural modification

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Gu, T.; Wu, W.-Y.; Dong, Z.-X.; Yu, S.-P.; Sun, Y.; Zhong, Y.; Lu, Y.-T.; Li, N.-G. Development and Structural Modification of BACE1 Inhibitors. Molecules 2017, 22, 4.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top